Stragen
Maurine Charvet has a diverse background in marketing, communication, and sales, with professional experience spanning across several organizations. At Allyane from September 2020 to September 2022, Maurine held the title of Chargée marketing et communication, focusing on neuromotor reprogramming methods while managing marketing initiatives, client relations, and event organization. Prior to that, Maurine worked at Pierre Fabre Group from September 2019 to August 2020 as an Animatrice Commerciale, promoting the Klorane brand and driving sales in various retail locations. Maurine's earlier roles include sales advisor and marketing intern at Le Gall Santé Services S.A.S, where responsibilities varied from managing commercial operations to executing promotional activities. Academic achievements include a Mastère Expert Digital from Icademie International and a MASTER Responsable en Développement Marketing et Vente from EKLYA School of Business.
This person is not in any offices
Stragen
Focusing on innovation for health solutions since 1990, Stragen is a global player in the development, registration and distribution of Generic drugs and Consumer Health products. Starting as a small API trading platform 30 years ago in Geneva, Switzerland, today Stragen operates in over 60 markets through a network of dynamic and collaborative partners, employing over 150 people and working with 10 dedicated affiliates worldwide. As a result of decades of experience and expertise in R&D, combined with our continuous commitment to advancing public health, we invest in the fundamental research through to the delivery of innovative and trusted health solutions to address unmet medical needs. We focus on two core activities: • Selected and Advanced Generics • Consumer Health products Our specialized and passionate scientific team consistently operates under the latest quality standards to deliver Swiss tailor-made solutions with the final product 100% manufactured in Europe. At Stragen, we understand that business models need to be reinvented to work within our competitive and fast-changing environment of the Pharma industry. We have identified how we can positively diversify our activities beyond the historical development and licensing out of Generic+ products, to the development of Consumer Health products as well as the development through to proof of concept of patented new drugs.